Pharmaceutical Standards

Applications 7-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-hydroxy-2-naphthalenesulfonic Acid is an intermediate used in the synthesis of 7-[[4-[Bis(3-Amino-3-oxopropyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methoxyphenyl)azo]-2-naphthalenesulfonic Acid (B426265), which acts as a non-peptide hormone receptor antagonist affecting physiological homeostasis and reproduction. Hormone antagonist.
References Arey, B. et al.: Endocrinol., 143, 3822 (2002); Wrobel, J. et al.: Synth. Comm., 32, 2695 (2002)

Applications 5-Methoxysalicylic acid

Applications 2-Amino-5-bromopyrazine-3-carboxylic Acid Methyl Ester is used as the starting material in the preparation of pyrazine derivatives that are AxI and c-Met receptor enzyme inhibitors. These inhibitors are useful in the treatment of tumors. 2-Amino-5-bromopyrazine-3-carboxylic Acid Methyl Ester is also used in the preparation of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.
References Rushton, L.; et al.: PCT Int. Appl. 119 pp. Patent 2009 CODEN:PIXXD2; Charrier, J-D.; et al.: J. Med. Chem, 54, 2320 (2011)

Applications 2,2'-(2-hydroxypropane-1,3-diyldisulfonyl)diethanol (cas# 67006-34-2) is a useful research chemical.

Applications Protected metabolite of Theobromine.
References Tarka, S.M., et al.: Clin. Pharmacol. Therap., 34, 546 (1983), Bonati, M., et al.: Toxicology, 30, 327 (1984)

Applications N-(4-Chlorophenyl)-O-methylisourea Sulfate Salt (~90%) is a cytotoxic agent which displays tumor inhibitory activity.
References Hendry, J. et al.: Brit. J. Pharmacol. Chemother., 6, 201 (1951);

Applications α-Naphthyl-d7 Glycidyl Ether is an intermediate in the synthesis of rac-Propranolol-d7 (P831803) which is the labeled analogue of Propranolol (P831800), a β−Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II).
References Bond, et al.: Nature, 213, 721 (1967), Hansteen, V., et al.: Br. Med. J., 284, 155 (1982), Diamond, S., et al.: J. Clin. Pharmacol., 28, 193 (1988),

Applications Diethyl-2,2,2,2',2',2'-d6-amine HCl (CAS# 1219805-68-1) is a useful isotopically labeled research compound.

Applications Jatrorrhizine iodide, is an alkaloid extract from the Berberidaceae family of plants displaying antioxidant activity.
References Ruiz, A. et al.: J. Agri. Food Chem., 62, 12407 (2014); Kim, J. et al.: Bioorg. Med. Chem., 22, 6047 (2014);

Applications C-18 Silica Gel for reverse phase flash chromatography.- 35-70 micron particles, capped with TMS
References J. Org. Chem., 48, 3589 (1983)

Applications trans-Caffeic Acid is a useful synthetic intermediate. It was used as a reactant to synthesize N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. It is also used to prepare caffeic acid phenethyl ester analogs with antitumor structures.
References Michalet, S., et al.: Bioorg. Med. Chem. Lett., 17, 1755 (2007); Nagaoka, T., et al.: Bioorg. Med. Chem., 10, 3351 (2002)

Applications 4-(Methoxy-d3)-α-methyl-(αS)-benzeneethanamine Hydrochloride is the labelled form of 4-Methoxyamphetamine Hydrochloride (M261015), which is the HCl salt of 4-Methoxyamphetamine. 4-Methoxyamphetamine is a designer drug belonging to the amphetamine class and releases 5-hydroxytryptamine in brain tissue.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Menon, M., et al.: J. Pharmacol. Exp. Ther., 197, 272 (1976);

Applications 3'-O-Levulinoyl-N-benzoyl-2'-deoxythymidine is a protected nucleotide derivative/building block.
References Kiuru, E., et al.: Helvetica Chimica Acta, 96, 1997-2008 (2013);

Applications N-[[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic Acid Methyl Ester is an impurity in the synthesis of Gyburide (G598350), a second generation sulfonylurea with hypoglycemic activity. Glyburide is an antidiabetic.
References Mizukami, et al.: Arzneimittel-Forsch., 19, 1413 (1969); Efendic, S., et al.: Proc. Nat. Acad. Sci. USA, 76, 5901 (1979); Feldman, J.M.: Pharmacotherapry, 5, 43 (1985);